Tuesday's Daily Dose: Potential lung cancer breakthrough, a warning about unprescribed Adderall use, and sports center for women

A new Ohio University study offers a glimmer of hope in the fight against lung cancer. Monica Robins has that story and more ...
News-Medical.Net

Blocking growth hormone receptor may improve treatment response in lung cancer

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

Growth hormone receptor could serve as possible target for improving lung cancer treatment

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...
EurekAlert!

New study identifies growth hormone receptor as possible target to improve lung cancer treatment

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments. The study published in the International Journal of Molecular Science ...

Novo Nordisk receives FDA approval for Sogroya in three new pediatric indications

Investing.com -- Novo Nordisk announced late Friday that the US Food and Drug Administration has approved three new indications for once-weekly Sogroya (somapacitan-beco) injection 5 mg, 10 mg, or 15 ...
Medindia

FDA approves Novo Nordisk's Sogroya® as the first and only once-weekly, long-acting growth hormone for three additional pediatric indications

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya® (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...